InfuSystem Holdings, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Revenue (Tables)

12 Months Ended

Dec. 31, 2025

The following table presents the Company’s disaggregated revenue by offering type (in thousands):


	Years Ended December 31,
	2025				2024
	Total Net Revenues		% of Total Net Revenues		Total Net Revenues		% of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	2,591	1.8	%	$	2,706	2.0	%
Third-Party Payer products	17,750		12.4	%	15,023		11.1	%
Patient Services revenue recognized over time:
Direct rental services	7,755		5.4	%	7,683		5.7	%
Third-Party Payer rental services	50,091		34.9	%	47,394		35.1	%
Total Patient Services accounted for under ASC 606	78,187		54.5	%	72,806		53.9	%
Device Solutions revenue recognized at a point in time:
Products	17,274		12.0	%	16,552		12.3	%
Services	11,829		8.2	%	8,861		6.6	%
Device Solutions revenue recognized over time:
Services	5,790		4.0	%	8,082		6.0	%
Total Device Solutions accounted for under ASC 606	34,893		24.3	%	33,495		24.9	%
Total Revenue Accounted for under ASC 606	113,080		78.8	%	106,301		78.8	%
Patient Services Lease Revenue	8,345		5.8	%	7,572		5.6	%
Device Solutions Lease Revenue	22,011		15.3	%	20,988		15.6	%
Total Revenue accounted for under ASC 842	30,356		21.2	%	28,560		21.2	%
Total Net Revenue	$	143,436	100.0	%	$	134,861	100.0	%